Inadequate clearance of translocated bacterial products in HIV-infected humanized mice

PLoS Pathogens

Volumn 6, Issue 4, 2010, Pages 1-10

  Hofer, Ursula ^a   Schlaepfer, Erika ^a   Baenziger, Stefan ^a   Nischang, Marc ^a   Regenass, Stephan ^a   Schwendener, Reto ^b   Kempf, Werner ^c   Nadal, David ^d   Speck, Roberto F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Kempf and Pfaltz Histological Diagnostics   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; DEXTRAN SULFATE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BACTERIUM; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; BACTERIA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; VIRAL LOAD;

EID: 77954075927     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000867     Document Type: Article

References (57)

1. Pandrea I, Sodora DL, Silvestri G, Apetrei C (2008) Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends in Immunology 29: 419-428.
2. Douek DC, Roederer M, Koup RA (2009) Emerging Concepts in the Immunopathogenesis of AIDS. Annual Review of Medicine 60.
3. Ancuta P, Kamat A, Kunstman KJ, Kim E-Y, Autissier P, et al. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3: e2516. doi:10.1371/journal.pone.0002516.
4. Gregson JN, Steel A, Bower M, Gazzard BG, Gotch FM, et al. (2009) Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS 23: 29-34.
5. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIVseropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197: 126-133.
6. Marchetti G, Bellistri GM, Borghi E, Tincati C, Ferramosca S, et al. (2008) Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22: 2035-2038.
7. Papasavvas E, Pistilli M, Reynolds G, Bucki R, Azzoni L, et al. (2009) Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients. AIDS 23: 369-375.
8. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
9. Heise C, Miller CJ, Lackner A, Dandekar S (1994) Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 169: 1116-1120.
10. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
11. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761-770.
12. Hofer U, Speck RF (2009) Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol 31: 257-266.
13. Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G (2008) Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 10: 36-46.
14. Gordon SN, Klatt NR, Bosinger SE, Brenchley JM, Milush JM, et al. (2007) Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 179: 3026-3034.
15. Pandrea IV, Gautam R, Ribeiro RM, Brenchley JM, Butler IF, et al. (2007) Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 179: 3035-3046.
16. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, et al. (2008) Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835.
17. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, et al. (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14: 421-428.
18. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti J-C, et al. (2004) Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice. Science 304: 104-107.
19. Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, et al. (2006) Disseminated and sustained HIV infection in CD34+ cord blood celltransplanted Rag2-/-gamma c-/-mice. Proc Natl Acad Sci U S A 103: 15951-15956.
20. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, et al. (2007) Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c- Rag2-/-{gamma}c-/- Mice. J Virol 81: 2700-2712.
21. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R (2006) HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology 3: 76.
22. Hofer U, Baenziger S, Heikenwalder M, Schlaepfer E, Gehre N, et al. (2008) RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol 82: 12145-12153.
23. Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protocols 2: 541.
24. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E (2002) Increased Proliferation and Apoptosis of Colonic Epithelial Cells in Dextran Sulfate Sodium-Induced Colitis in Rats. Digestive Diseases and Sciences 47: 1447-1457.
25. Tessner TG, Cohn SM, Schloemann S, Stenson WF (1998) Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115: 874-882.
26. Li Q, Estes JD, Duan L, Jessurun J, Pambuccian S, et al. (2008) Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis 197: 420-429.
27. Hopf U, Ramadori G, Moller B, Galanos C (1984) Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med 2: 13-19.
28. Freudenberg MA, Freudenberg N, Galanos C (1982) Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol 63: 56-65.
29. Gitter A, Bendfeldt K, Schulzke J, Fromm M (2000) Leaks in the epithelial barrier caused by spontaneous and TNF-{alpha}-induced single-cell apoptosis. FASEB J 14: 1749-1753.
30. Smith AM, Rahman FZ, Hayee BH, Graham SJ, Marks DJB, et al. (2009) Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206: 1883-1897.
31. Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in Immunology 30: 475-487.
32. Adib-Conquy M, Cavaillon J-M (2002) Gamma Interferon and Granulocyte/ Monocyte Colony-stimulating Factor Prevent Endotoxin Tolerance in Human Monocytes by Promoting Interleukin-1 Receptor-associated Kinase Expression and Its Association to MyD88 and Not by Modulating TLR4 Expression. Journal of Biological Chemistry 277: 27927-27934.
33. Schuchmann M, Hermann F, Herkel J, van der Zee R, Galle PR, et al. (2004) HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS tolerance of hepatic Kupffer cells. Immunology Letters 93: 199-204.
34. Dalpke AH, Lehner MD, Hartung T, Heeg K (2005) Differential effects of CpGDNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 116: 203-212.
35. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, et al. (2007) Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection. Gastroenterology 133: 1627-1636.
36. Lester RT, Yao X-D, Ball TB, McKinnon LR, Omange WR, et al. (2009) HIV- 1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers. PLoS ONE 4: e5644. doi:10.1371/journal. pone.0005644.
37. Muthumani K, Hwang DS, Choo AY, Mayilvahanan S, Dayes NS, et al. (2005) HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int Immunol 17: 103-116.
38. Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM (1995) HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 154: 6132-6139.
39. Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, et al. (2003) Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. Journal of Clinical Virology 26: 247-263.
40. KedzierskaKaf, MakJag, JaworowskiAae, GreenwayAbg, VioloAa, et al. (2001) nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS 15: 945-955.
41. Baqui AA, Meiller TF, Zhang M, Falkler WA, Jr. (1999) The effects of HIV viral load on the phagocytic activity of monocytes activated with lipopolysaccharide from oral microorganisms. Immunopharmacol Immunotoxicol 21: 421-438.
42. Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, et al. (1999) The Interleukin-12-Mediated Pathway of Immune Events Is Dysfunctional in Human Immunodeficiency Virus-Infected Individuals. Blood 94: 1003-1011.
43. Rockstroh JK, Kreuzer KA, Sauerbruch T, Spengler U (1998) Protein levels of interleukin-12 p70 Holomer, its p40 chain and interferon-gamma during advancing HIV infection. Journal of Infection 37: 282-286.
44. Byrnes AA, Harris DM, Atabani SF, Sabundayo BP, Langan SJ, et al. (2008) Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. J Leukoc Biol 84: 1447-1453.
45. Ayehunie S, Sonnerborg A, Yemane-Berhan T, Zewdie DW, Britton S, et al. (1993) Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol 91: 37-42.
46. von Sydow M, Sonnerborg A, Gaines H, Strannegard O (1991) Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 7: 375-380.
47. Shen R, Richter HE, Clements RH, Novak L, Huff K, et al. (2009) Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection. J Virol 83: 3258-3267.
48. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, et al. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362.
49. Orenstein JM, Fox C, Wahl SM (1997) Macrophages as a Source of HIV During Opportunistic Infections. Science 276: 1857-1861.
50. Baenziger S, Heikenwalder M, Johansen P, Schlaepfer E, Hofer U, et al. (2009) Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 113: 377-388.
51. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077-1087.
52. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. (2004) Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science 303: 1526-1529.
53. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16: 83-92.
54. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time. Science 271: 1582-1586.
55. Wolthers KC, Wisman GBA, Otto SA, de Roda Husman A-M, Schaft N, et al. (1996) T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4+ T Cell Turnover. Science 274: 1543-1547.
56. Cullen BR, Greene WC (1989) Regulatory pathways governing HIV-1 replication. Cell 58: 423-426.
57. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, et al. (2006) Clodronate-liposome-mediated depletion of tumour associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95: 272-281.